Chemoradiotherapy in Patients with Pancreatic Carcinoma: Phase-I Study with a Fixed Radiation Dose and Escalating Doses of Weekly Gemcitabine

Publisher： Karger

E-ISSN： 1424-3911|6|1-2|109-116

ISSN： 1424-3903

Source： Pancreatology, Vol.6, Iss.1-2, 2006-04, pp. : 109-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 635-641

Karger

Access to resources Recommend Favorite

Phase I Study of Prolonged-Infusion Gemcitabine Combined with Cyclophosphamide in Patients with Metastatic Carcinoma of the Breast: Tolerability of an Optimal Dose Schedule

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I–II Study

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine: A Single-Institute Study

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 333-337

Karger

Access to resources Recommend Favorite

A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study

By  

Oncology, Vol. 62, Iss. 4, 2002-07 ,pp. : 299-304

Karger

Access to resources Recommend Favorite